Results 221 to 230 of about 13,217 (287)
Some of the next articles are maybe not open access.

Osteonecrosis of the jaw

Current Rheumatology Reports, 2008
Bisphosphonates are effective therapy for osteoporosis, Paget's disease, and metastatic bone disease. Generally, the side effects of bisphosphonates are minimal. Recently, an uncommon adverse reaction affecting the maxilla or mandible, called osteonecrosis of the jaw, has been reported, especially in those patients receiving high doses of ...
Philip N, Sambrook, Peter, Ebeling
  +11 more sources

Use of Leukocyte-rich and Platelet-rich Fibrin (L-PRF) Adjunct to Surgical Debridement in the Treatment of Stage 2 and 3 Medication-Related Osteonecrosis of the Jaw

The Journal of craniofacial surgery (Print), 2023
Medication-related osteonecrosis of the jaw (MRONJ) is characterized by exposed necrotic bone persisting for more than 8 weeks in the maxillofacial region in patients using antiresorptive or antiangiogenetic drugs for several treatment options like bone ...
Gül Merve Yalcin-Ülker   +4 more
semanticscholar   +1 more source

Prevalence of Medication-Related Osteonecrosis of the Jaw in Osteoporotic Patients Treated with Antiresorptive Drugs at Pranangklao Tertiary Care Hospital in Nonthaburi Province, Thailand

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2023
Background: Medication-related osteonecrosis of the jaw (MRONJ) could disturb the quality of life of the patients. In Thailand, published data reporting the prevalence of MRONJ is scarce.

semanticscholar   +1 more source

Prosthodontic rehabilitation of a patient with nintedanib-induced osteonecrosis of the jaw: A clinical report.

The Journal of prosthetic dentistry (Print), 2023
Medication-related osteonecrosis of the jaw results in extensive excision and proves challenging to rehabilitate prosthetically. This article describes the prosthodontic rehabilitation of medication-related osteonecrosis of the jaw induced by nintedanib.
A. John   +3 more
semanticscholar   +1 more source

Spontaneous Recovery of Pathological Fracture Caused by Medication-Related Osteonecrosis of the Jaw

The Journal of craniofacial surgery (Print), 2023
Pathological fracture is one of the most serious complications in medication-related osteonecrosis of the jaw (MRONJ). This case is a report of an 87-year-old woman who had been diagnosed with pathological fracture due to MRONJ.
Joon Hyeok Jung   +4 more
semanticscholar   +1 more source

Association Between Malignant Diseases and Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis

The Journal of craniofacial surgery (Print), 2022
Purpose: The aim was to identify whether malignant diseases increase the risk of medication-related osteonecrosis of the jaw (MRONJ) occurrence when patients are exposed to bisphosphonate, antiresorptive or antiangiogenic drugs.
Sheng Yao   +4 more
semanticscholar   +1 more source

Vascular Analysis of Soft Tissues Around the Bone Lesion in Osteoradionecrosis, Medication-Related Osteonecrosis, and Infectious Osteomyelitis of the Jaw

The Journal of craniofacial surgery (Print), 2022
Objective: The histopathological differences of the surrounding soft tissues in osteoradionecrosis of the jaw, medication-related osteonecrosis of the jaw as well as infectious osteomyelitis of the jaw patients were rarely investigated.
Zhuo Wang   +5 more
semanticscholar   +1 more source

Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2021
Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of antiresorptive (AR) drugs such as bisphosphonates (BP) and denosumab (Dmab).
R. Schoenhof   +7 more
semanticscholar   +1 more source

Osteonecrosis of the Jaw

Journal of Clinical Densitometry, 2017
female, 77 ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy